Medpace Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2015
Net Income	282.81	245.37	181.85	145.38	100.44	Upgrade
Depreciation & Amortization	45.97	40.36	37.41	33.45	33.14	Upgrade
Share-Based Compensation	20.52	21.41	14.47	13.78	20.74	Upgrade
Other Operating Activities	84.07	80.91	29.6	66.06	47.55	Upgrade
Operating Cash Flow	433.37	388.05	263.33	258.68	201.87	Upgrade
Operating Cash Flow Growth	11.68%	47.36%	1.80%	28.14%	28.92%	Upgrade
Capital Expenditures	-36.65	-36.88	-28.27	-31.34	-17.91	Upgrade
Other Investing Activities	2.02	-1.86	-3.09	0.13	-1.23	Upgrade
Investing Cash Flow	-34.63	-38.74	-31.36	-31.21	-19.14	Upgrade
Share Issuance / Repurchase	-132.64	-825.78	-44.45	-82.28	6.52	Upgrade
Debt Issued / Paid	-50	50	0	0	-80.44	Upgrade
Financing Cash Flow	-182.64	-775.78	-44.45	-82.28	-73.92	Upgrade
Exchange Rate Effect	1.08	-6.57	-3.97	0.67	-0.17	Upgrade
Net Cash Flow	217.18	-433.04	183.54	145.85	108.64	Upgrade
Free Cash Flow	396.73	351.17	235.06	227.34	183.96	Upgrade
Free Cash Flow Growth	12.97%	49.40%	3.40%	23.58%	30.87%	Upgrade
Free Cash Flow Margin	21.04%	24.05%	20.58%	24.55%	21.37%	Upgrade
Free Cash Flow Per Share	12.91	10.84	6.55	6.38	5.13	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).